Katrina Parker
Dr. Katrina Parker grew up in Detroit, Michigan and attended Michigan State University where she obtained her Bachelor of Science degree in Microbiology & Public Health. She has served as the Interim Director of Pediatric Endocrinology at the University of Alabama at Birmingham where she was instrumental in doing the groundwork in establishing the Pediatric Endocrinology Fellowship Program and was on the advisory board for Genetech, Inc. Regarding growth hormone therapy in pediatrics. Dr. Parker also served advisory on the Newborn Screening Committees in Alabama and Texas. Internationally, she collaborated with Gemini to organize programs for medical students and healthcare professional in Ethiopia. Since joining Ross University School of Medicine, she has served as the Endocrine I & II Module Director, Basic Sciences Representative on the Curriculum Committee and Faculty Advisor to White Coats for Black Lives and Organization for African Students.
Residency:
Wayne State University Affiliated Hospitals – Internal Medicine Internship
Wayne State University Affiliated Hospitals – Children's Hospital of Michigan –Pediatrics Internship & Residency
Fellowship:
Pediatric Endocrinology, University of Pittsburgh – Children's Hospital of Pittsburgh
2001, 2007 & 2009 Best Doctors in America;
2007 & 2008 Top Doctors for Kids
2000-2003 American Diabetes Association & National Committee for Quality Assurance Provider Recognition Program Certificate for Recognition
American Academy of Pediatrics
Pediatric Endocrine Society
Selected Peer-Reviewed Publications:
Ye J, Mack D, Fry-Johnson Y, Parker K. Health Care Access and Utilization Among US- Born and Foreign- Born Asian Americans: J Immigrant Minority Health. 14(5):731-737, 2012;
Wyatt D, Parker KL, Kemp SF, Chiang J, Davis A. The Evaluation and Follow-Up of Children Referred to Pediatric Endocrinologist for Short Stature: Int J of PediatrEndol. 2010; 2010:652013.
Bell J, Parker KL, Hoffman AR, Swinford RD, Lippe B. Long-Term Safety of Recombinant Human Growth Hormone in Children: J ClinEndocrinolMetab 95: (1):167-177, 2010.
Bolar KP, Hoffman AR, Maneatis T, Lippie B. Long Term Safety of Recombinant Human Growth Hormone in Turner Syndrome: J ClinEndocrinolMetab 93:344-351, 2008.
Parker KL, Wyatt DT, Blethen SL, Baptista J, Price L. Screening Girls with Turner Syndrome: The National Cooperative Growth Study Experience: J Pediatr 143:133-135; 2003.
Parker KL, Hunold JJ, Blethen SL. Septo-Optic Dysplasia/Optic Nerve Hypoplasia: Data from the National Cooperative Growth Study Experience: JPEM 15: 697-700: 2002.
Wingo KR, Parker KL, Young DW. Familial Pheochromocytoma: PediatrAdoles Med 1994;148:605-606.
Hedlund GL, Royal SA, Parker KL. Disorders of Puberty: A Practical Imaging Approach. Seminars in CT, Ultrasound and MRI 1994; 15(1):49-77.
Parker KL. Congenital Adrenal Hyperplasia Screening in Alabama, The Scope 1994;2(3):6-7.
Parker KL.Congenital Adrenal Hyperplasia Screening in Alabama.The Alabama Pediatrician 1994; 13:10-11.
Benfield MR, Parker KL, Waldo FB, Overstreet SL, Kohaut ED. Growth Hormone in the Treatment of Growth Failure in Children After Renal Transplantation. Transplantation 1993; 55(2):305-308.
Books:
Parker, KL. Teen’s Guide to Living with Diabetes. Facts On File, Inc. New York, New York; Checkmark Books 2008.
Book Chapters:
Parker, KL. Diabetes in Childhood, Hospitals and Doctors Guide 1:2000.
Parker KL, Lee PA.“Treatment of Girls with Central Precocious Puberty with Depot GnRH Analogue Therapy.”(Eds T M Plant & P A Lee), pp. 297-302, Journal of Endocrinology LTD, Bristol, 1995.The Neurobiology of Puberty.
Audio-Visual Material:
Webcast Series on Growth Hormone Deficiency; Concerns about GHD, Testing and Diagnosis of GHD and Treatment and Transitioning.
www.magicfoundation.org 2002−current.